Law › Intellectual Property / Patent / Copyright

Research Handbook on Intellectual Property and the Life Sciences

Name: Research Handbook on Intellectual Property and the Life Sciences
Brand: Edward Elgar Publishing
SKU: 9781783479443
Price: 2875.08 HKD
Availability: InStock
Author: Duncan Matthews; Herbert Zech
ISBN: 9781783479443

Edited by Duncan Matthews · Herbert Zech

Edward Elgar Publishing June 2017

Specifications

ISBN-13: 9781783479443
Publisher: Edward Elgar Publishing
Publication: June 2017
Format: Hardback
Jurisdiction: International ? Countri(es) for reference only

Details

Intellectual property (IP) is a key component of the life sciences, which is becoming one of the most dynamic and innovative fields of technology today. At the same time, the relationship between IP and the life sciences is raising new public policy dilemmas.

The Research Handbook on Intellectual Property and the Life Sciences comprises contributions by leading experts from academia and industry that confront current debates and controversies at the intersection of IP and the life sciences through in-depth analyses of key topics including pharmaceuticals, diagnostics and genes, plant innovations, stem cells, the role of competition law and access to medicines.

The first section of this book highlights the importance of IP for medicines and pharmaceuticals, discussing topics including gene patents, and the second section deals with agricultural sector issues such plant innovations. Section three of the book covers areas of research and development in the life sciences, such as stem cell research, and raises questions about incorporating ethical considerations into patent law.

While the primary focus of the book is on Europe and the United States, the fourth section includes country-specific case studies on Australia, Brazil, China, India, Japan, Kenya, South Africa and Thailand to provide a truly international perspective.

This Handbook is written in an accessible style that will appeal to intellectual property law scholars, practitioners, and experts in the life sciences who are interested in the legal implications of IP for the life sciences.

Preface

Part I - Medicine and Pharmaceutics
1. Patenting Biosimilars Claudia Mund
2. Patenting Diagnostics Dieter Wachter
3. Patenting Human Genes in Europe- And how it compares to the US and Australia Timo Minssen
4. Patenting Human Genes in the United States Samantak Gosh
5. An Exorbitant Monopoly: The High Court of Australia, Myriad Genetics, and Gene Patents Matthew Rimmer
6. Exclusivity for Biologics Duncan Matthews

Part II - Agricultural Sector (Crop Sciences)
7. Protection of Plant Innovations Gert Wurtenberger
8. Patenting Non Transgenic Plants in the EU Michael Kock
9. Non-Obvious Plants Mark D. Janis
10. Transgenic Plants James Allred
11. Convention on Biological Diversity and Regulatory Law as Plant Protection Claudio Chiarolla
12. Patents on Native Traits: What Scope of Protection? Axel Metzger

Part III - Research and Development
13. The European Union's IP Policy & Funding of Stem Cell Research Aurora Plomer
14. Stem Cell Patents in the United States John M Golden
15. Early Stage Patenting, the U.S. Bayh-Dole Act, and the Anti-Commons Hypothesis Charles R. McManis and Brian Yagi
16. IP in Research and Development Agreements Melanie Graf and Herbert Zech
17. Patent pools and clearinghouses in the life sciences: back to the future Geertrui Van Overwalle

Part IV - Country Case Studies in IP and the Life Sciences
18. Understanding the Brazilian Patent Reform Pedro Paranagua
19. IP protection in the life sciences in China Lin Xiuqin and Zhang Xinfeng
20. Diverse Harmonization: Indian Example Srividhya Ragavan
21. Life Science Research and Patents in Japan: A Comparative Study of Life Science Invention Patentability between the Japanese and U.S. Patent Acts Toshiko Takenaka
22. Intellectual Property and the Life Sciences in Kenya: Enforcement and Access to Medicines John Harrington
23. IP and Life Sciences: A Case Study of South Africa Tenu Avafia
24. Thailand's Compulsory Licenses and the Increase of Investment Arbitration David Degen

Part V - Boundaries of IP and the Life Sciences
25. Parallel Imports within the European Union Gert Wurtenberger
26. Pay for Delay Agreements Claudia Seitz
27. Abusive Filing of IP Rights Andreas Heinemann

Index

HKD 2,875.08 −3%

HKD 2,964.00

Inclusive of HK delivery

Ready to ship

Quantity